Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Nov;54(6):1359-1362.
doi: 10.1007/s43441-020-00158-8. Epub 2020 May 1.

Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion

Peter Yamoah  1   2 , Thelma Mpoku Alalbila  3 , Varsha Bangalee  4 , Frasia Oosthuizen  4
Affiliations
Editorial

Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion

Peter Yamoah et al. Ther Innov Regul Sci. 2020 Nov.

Abstract

The Coronavirus Disease 2019 (COVID-19) is rapidly spreading throughout the world after emerging in China in December 2019. Currently, there are no approved treatments for COVID-19 based on large clinical trial data, and hence, management involves infection prevention and control measures and supportive care. With anecdotal reports and in vitro studies suggesting that certain medicines already in use for treatment of other conditions could be viable treatment options, there has been an increased demand for these therapies which could have adverse consequences on patients and healthcare systems. Toxicity from these medicines resulting from a mad rush for them at community pharmacies and pressure on physicians to prescribe for individuals who do not have the infection are worth noting. Furthermore, the indiscriminate use of these medicines could result in viral resistance as well as acute shortage such that patients who routinely take them for other conditions may not get them.

Keywords: COVID-19; Chloroquine; Coronaviruses; Hydroxychloroquine; Pharmacovigilance.

PubMed Disclaimer

Comment on

References

    1. Wetsman N. Who declares the outbreak of the new coronavirus is a pandemic, March 11, 2020. https://www.theverge.com/2020/3/11/21156325/coronavirus-pandemic-who-dec.... Accessed 22 Mar 2020.
    1. Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation and treatment of coronavirus (COVID-19) [Updated 2020 Mar 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. https://www.ncbi.nlm.nih.gov/books/NBK554776/. - PubMed
    1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi: 10.1056/nejmoa2001017. - DOI - PMC - PubMed
    1. Kuiken T, Fouchier RAM, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet. 2003;362:263–270. doi: 10.1016/S0140-6736(03)13967-0. - DOI - PMC - PubMed
    1. de Groot RJ, Baker SC, Baric RS, et al. Middle east respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol. 2013;87:7790–7792. doi: 10.1128/JVI.01244-13. - DOI - PMC - PubMed

LinkOut - more resources